DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,359,000 | -10.9% | 216,557 | -4.0% | 0.23% | -7.7% |
| Q2 2021 | $8,258,000 | -19.6% | 225,567 | -1.5% | 0.25% | -25.5% |
| Q1 2021 | $10,270,000 | -57.7% | 229,040 | -46.2% | 0.33% | -59.0% |
| Q4 2020 | $24,292,000 | +88.4% | 425,661 | +69.3% | 0.80% | +43.6% |
| Q3 2020 | $12,896,000 | -16.0% | 251,381 | -2.2% | 0.56% | -18.6% |
| Q2 2020 | $15,350,000 | – | 257,031 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
| Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
| BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
| Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
| ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
| Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
| Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
| Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
| Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |